Novartis definitely know more about what Mesoblast is reporting to the market (ie. shareholders like you and I). You're going to buy into the optimism that SI shares when he makes the quarterly announcements.
Novartis' experience in this field allow them to see through the words and understand the statistics - particularly when it comes to what they're going to present to the OTAT.
Novartis definitely know more about what Mesoblast is reporting...
-
- There are more pages in this discussion • 551 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
-0.105(8.37%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.23 | $1.14 | $9.583M | 8.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 25000 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |